As I have written before, molecular targeted therapy is an epoch-making advancement. The “miraculous” efficacy of ERSA in the treatment of lung cancer has significantly improved the quality of life and survival time of many patients with advanced lung cancer, and has been “sought after” by most patients, and even some unsuitable patients want to try it, hoping for a miracle! The majority of patients are “in demand” and even some unsuitable patients want to try it, hoping for a miracle! In front of the huge market demand, Chinese shrewd businessmen made various versions of fake drugs, deceiving countless patients and their families, delaying the patient’s condition, delaying the treatment, and even leading to the patient’s early death. Yan Ming, Department of Thoracic Surgery, Henan Cancer Hospital